Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Ontario Votes 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GILD
Recent news which mentions GILD
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
Gilead Sciences Acquires Jounce Therapeutics Cancer Immunotherapy Program
December 28, 2022
Tickers
GILD
JNCE
Tags
Penny Stocks
GILD
Briefs
From
Benzinga
Why Is Jounce Therapeutics (JNCE) Stock Up 70% Today?
December 28, 2022
Tickers
GILD
JNCE
MRK
Tags
NASDAQ:GILD,NASDAQ:JNCE,NYSE:MRK
MRK
JNCE
From
InvestorPlace
Tesla, Apple, Lightjump, Southwest, Gilead: Why These 5 Stocks Are Drawing Investors' Attention Today
December 27, 2022
Tickers
AAPL
GILD
LJAQ
LUV
Tags
big tech
Markets
LJAQ
From
Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
December 27, 2022
Tickers
GILD
Tags
Dividends
Earnings
GILD
From
Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
Trading Ideas
Biotech
BIIB
From
Benzinga
3 Stocks That Could Soar in a Santa Claus Rally
December 25, 2022
Tickers
GILD
NVCR
PFE
Tags
NVCR
Recent Press Releases
GILD
From
Motley Fool
3 Nasdaq Stocks That Are Up 25% in 3 Months
December 23, 2022
Tickers
BIIB
GILD
NVDA
Tags
Recent Press Releases
BIIB
NVDA
From
Motley Fool
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
December 22, 2022
Tickers
GILD
Tags
Biotech
News
Large Cap
From
Benzinga
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
Tickers
AAL
AAPL
AMC
AMZN
Tags
AMZN
VBINX
BX:TMUBMUSD10Y
From
MarketWatch
Analyzing Gilead Sciences's Short Interest
December 21, 2022
Tickers
GILD
Tags
GILD
Short Sellers
Short Ideas
From
Benzinga
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Tickers
GILD
MRK
RCUS
RHHBY
Tags
MRK
Market News
RCUS
From
InvestorPlace
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
Tickers
AZN
GILD
LLY
MDGL
Tags
General
MRK
Movers
From
Benzinga
Why Is Gilead Sciences Stock Sliding Tuesday?
December 20, 2022
Tickers
GILD
Tags
why it's moving
Movers
Trading Ideas
From
Benzinga
Gilead-Arcus Partnered Domvanalimab Combo Study Show Improved Progression-Free Survival In Lung Cancer Patients
December 20, 2022
Tickers
GILD
RCUS
Tags
Movers
News
General
From
Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
December 12, 2022
Tickers
DJI
GILD
Tags
Market News
GILD
^DJI
From
Motley Fool
Why Is Arcellx (ACLX) Stock Up 25% Today?
December 09, 2022
Tickers
ACLX
GILD
Tags
ACLX
NASDAQ:ACLX,NASDAQ:GILD
Today's Market
From
InvestorPlace
Gilead's Kite, Arcellx Ink Over $300M Collaboration Pact For Late-Stage Multiple Myeloma Candidate
December 09, 2022
Tickers
ACLX
GILD
Tags
GILD
Briefs
Health Care
From
Benzinga
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 15 Years
December 08, 2022
Tickers
GILD
Tags
GILD
Earnings
Dividends
From
Benzinga
Is Gilead Sciences a Buy?
December 08, 2022
Tickers
GILD
Tags
Recent Press Releases
Market News
GILD
From
Motley Fool
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
Tickers
ALLO
BMY
CRBU
CRSP
Tags
EDIT
GILD
Penny Stocks
From
Benzinga
Is Gilead Sciences Stock Still a Buy After Soaring in 2022?
December 08, 2022
Tickers
GILD
Tags
GILD
Market News
Recent Press Releases
From
Motley Fool
Gilead Sciences Unusual Options Activity
December 02, 2022
Tickers
GILD
Tags
Markets
BZI/UOA
Options
From
Benzinga
Here’s how one hedge fund is going aginst the grain and beating the markets
December 02, 2022
Tickers
ADM
ALL
BIIB
BMWYY
Tags
BMWYY
MPC
MET
From
MarketWatch
10 Health Care Stocks With Whale Alerts In Today's Session
December 01, 2022
Tickers
BDX
BNTX
DGX
GILD
Tags
PFE
Market News
BZI/AUOA
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
Tickers
ABC
ACGL
ACM
ADP
Tags
FDMT
Benzinga
LLY
From
Benzinga
Expert Ratings for Gilead Sciences
December 01, 2022
Tickers
GILD
Tags
Benzinga
BZI/AAR
Market News
From
Benzinga
The Top Healthcare Stocks to Buy With $100
December 01, 2022
Tickers
BMY
GILD
Tags
GILD
Market News
Recent Press Releases
From
Motley Fool
2 Reasons This Stock Could Outperform in 2023
November 30, 2022
Tickers
GILD
Tags
Recent Press Releases
GILD
Market News
From
Motley Fool
These 3 Stocks Are Rallying While the Rest of the Market Plunges
November 30, 2022
Tickers
GILD
META
RCL
TJX
Tags
Recent Press Releases
RCL
Market News
From
Motley Fool
Gilead-Arcus Biosciences Partnered Lung Cancer Therapy Shows Continuous Positive Efficacy Measures
November 28, 2022
Tickers
GILD
RCUS
Tags
Biotech
Trading Ideas
Large Cap
From
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.